Chung-Hsi Wang

913 total citations · 1 hit paper
11 papers, 680 citations indexed

About

Chung-Hsi Wang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Chung-Hsi Wang has authored 11 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Chung-Hsi Wang's work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (6 papers). Chung-Hsi Wang is often cited by papers focused on Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (6 papers). Chung-Hsi Wang collaborates with scholars based in Canada and Japan. Chung-Hsi Wang's co-authors include Yuki Kagoya, Tingxi Guo, Mark Anczurowski, Marcus O. Butler, Kayoko Saso, Naoto Hirano, Mark D. Minden, Shinya Tanaka, Kenji Murata and Hiroshi Saijo and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Biotechnology.

In The Last Decade

Chung-Hsi Wang

11 papers receiving 665 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects

2018 446 citations Yuki Kagoya, Shinya Tanaka et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chung-Hsi Wang Canada	7	568	304	247	183	165	11	680
John Lattin United States	5	648 1.1×	294 1.0×	256 1.0×	213 1.2×	162 1.0×	8	742
Aaron Zhang United States	5	465 0.8×	259 0.9×	142 0.6×	160 0.9×	124 0.8×	8	579
Ruocong Zhao China	11	441 0.8×	240 0.8×	162 0.7×	134 0.7×	111 0.7×	15	532
Decheng Song United States	7	468 0.8×	229 0.8×	182 0.7×	173 0.9×	146 0.9×	13	621
Anna Wing United States	4	738 1.3×	250 0.8×	260 1.1×	262 1.4×	262 1.6×	6	785
Xueqiang Zhao China	10	500 0.9×	299 1.0×	189 0.8×	171 0.9×	123 0.7×	14	667
Gordon Weng-Kit Cheung United Kingdom	8	706 1.2×	200 0.7×	423 1.7×	264 1.4×	291 1.8×	13	836
Andreas Mades Germany	5	430 0.8×	140 0.5×	180 0.7×	181 1.0×	157 1.0×	6	516
Trisha R. Berger United States	9	373 0.7×	175 0.6×	147 0.6×	133 0.7×	102 0.6×	20	469
Katrin Mestermann Germany	4	430 0.8×	149 0.5×	161 0.7×	178 1.0×	139 0.8×	11	493

Countries citing papers authored by Chung-Hsi Wang

Since Specialization

Citations

This map shows the geographic impact of Chung-Hsi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung-Hsi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung-Hsi Wang more than expected).

Fields of papers citing papers by Chung-Hsi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung-Hsi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung-Hsi Wang. The network helps show where Chung-Hsi Wang may publish in the future.

Co-authorship network of co-authors of Chung-Hsi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chung-Hsi Wang. A scholar is included among the top collaborators of Chung-Hsi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung-Hsi Wang. Chung-Hsi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Murata, Kenji, Dalam Ly, Hiroshi Saijo, et al.. (2022). Modification of the HLA-A*24:02 Peptide Binding Pocket Enhances Cognate Peptide-Binding Capacity and Antigen-Specific T Cell Activation. The Journal of Immunology. 209(8). 1481–1491. 2 indexed citations

2.

Sugata, Kenji, Yukiko Matsunaga, Yūki Yamashita, et al.. (2021). Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells. Nature Biotechnology. 39(8). 958–967. 14 indexed citations

3.

Kagoya, Yuki, Tingxi Guo, Brian Yeung, et al.. (2020). Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy. Cancer Immunology Research. 8(7). 926–936. 126 indexed citations

4.

Anczurowski, Mark, Kenji Sugata, Yukiko Matsunaga, et al.. (2019). Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP84GGPM87. Journal of Autoimmunity. 102. 114–125. 2 indexed citations

5.

Kagoya, Yuki, Hiroshi Saijo, Yukiko Matsunaga, et al.. (2018). Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells. Journal of Autoimmunity. 97. 10–21. 38 indexed citations

6.

Kagoya, Yuki, Munehide Nakatsugawa, Kayoko Saso, et al.. (2018). DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Nature Communications. 9(1). 1915–1915. 22 indexed citations

7.

Kagoya, Yuki, Shinya Tanaka, Tingxi Guo, et al.. (2018). A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects. Nature Medicine. 24(3). 352–359. 446 indexed citations breakdown →

8.

Anczurowski, Mark, Yūki Yamashita, Munehide Nakatsugawa, et al.. (2018). Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly. Scientific Reports. 8(1). 4804–4804. 7 indexed citations

9.

Guo, Tingxi, Yuki Kagoya, Mark Anczurowski, et al.. (2017). A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs. The Journal of Immunology. 200(2). 500–511. 18 indexed citations

10.

Guo, Tingxi, Toshiki Ochi, Munehide Nakatsugawa, et al.. (2016). Generating <em>De Novo</em> Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain. Journal of Visualized Experiments. 2 indexed citations

11.

Chamoto, Kenji, Tingxi Guo, S.W. Scally, et al.. (2016). Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs. The Journal of Immunology. 198(3). 1056–1065. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact